Jiabing Ran | Materials Science | Best Researcher Award

Best Researcher Award

Jiabing Ran
China Three Gorges University, China
Jiabing Ran
Affiliation China Three Gorges University
Country China
Scopus ID 56012790200
Documents 60
Citations 1887
h-index 25
Subject Area Materials Science
Event International Phenomenological Research Awards
ORCID 0000-0002-8474-7368
Google Scholar pOJg4moAAAAJ

Jiabing Ran is a researcher in biomedical materials science and regenerative medicine affiliated with China Three Gorges University. His academic work focuses on smart responsive hydrogels, tissue engineering, implant integration, and advanced drug delivery systems. His research integrates biomaterials engineering with translational medical applications, particularly in bone regeneration, anti-inflammatory therapeutics, and hydrogel-mediated biomedical interventions.[1]

Abstract

Jiabing Ran has contributed to the development of multifunctional biomaterials and hydrogel-based therapeutic systems for regenerative medicine and biomedical engineering. His research emphasizes smart responsive hydrogel platforms, macrophage regulation, implant osseointegration, antibacterial therapy, and tissue repair applications. Through interdisciplinary integration of materials science and biological engineering, his studies address translational challenges in bone defect repair, ophthalmic therapeutics, tendinitis treatment, and drug delivery systems. His publication record and patent portfolio indicate sustained contributions to advanced biomaterials research and clinical translation.[2]

Keywords

Tissue engineering, supramolecular hydrogel, metal organic framework, regenerative medicine, biomaterials, smart drug delivery, injectable hydrogel, macrophage polarization, osseointegration, antibacterial biomaterials.

Introduction

Jiabing Ran earned a Doctor of Engineering degree in Materials Physical Chemistry from Wuhan University in 2018 and completed postdoctoral research at Karolinska Institutet. He currently focuses on biomaterials, biomedical hydrogels, regenerative medicine, and translational therapeutic development at China Three Gorges University.[1]

His academic output includes more than sixty peer-reviewed scientific publications and multiple authorized patents related to hydrogel technologies, implant coatings, ophthalmic therapeutics, and injectable biomaterials. His work has appeared in internationally recognized journals within biomaterials science and biomedical engineering.[3]

Research Profile

Jiabing Ran’s research focuses on responsive biomaterials and multifunctional hydrogels for biomedical applications. His studies investigate controlled drug delivery, tissue regeneration, and hydrogel-based therapies for bone defects, osteoarthritis, keratitis, diabetic injuries, and tendon disorders.[4]

His completed and ongoing research projects include studies funded by the Hubei Provincial Natural Science Foundation of China and regional science and technology initiatives. These projects focus on macrophage polarization, antibacterial hydrogel coatings, injectable therapeutic systems, and biomaterial-assisted osseointegration mechanisms.[2]

  • Sequential macrophage polarization on titanium surfaces for osseointegration enhancement.
  • Injectable ellagic acid hydrogel systems for osteoarthritis treatment.
  • Hydrogel-coated antibacterial urinary catheter development.
  • Glucose-responsive injectable hydrogels for diabetic bone repair.

Research Contributions

Jiabing Ran has contributed to catechol-like natural product delivery systems based on phenylboronic ester chemistry for controlled drug release and regenerative medicine. His research on hydrogel-mediated macrophage polarization advances understanding of biomaterial–immune interactions during tissue healing and regeneration.[4]

His studies also address multifunctional hydrogel systems capable of simultaneously targeting bacterial infection, inflammation, and tissue regeneration. Such biomaterials have applications in orthopedic engineering, implant coatings, ophthalmology, and wound healing technologies.[5]

  • Development of injectable hydrogels for infected bone defect repair.
  • Hydrogel-coated titanium implant surfaces for enhanced osseointegration.
  • Microneedle-based sustained drug delivery systems for tendinopathy therapy.
  • Sustained ophthalmic delivery systems for keratitis and glaucoma therapy.
  • Supramolecular pH-responsive hydrogel engineering for biomedical applications.

Publications

Jiabing Ran has published more than sixty peer-reviewed scientific articles in internationally recognized journals, including Journal of Controlled Release, Acta Biomaterialia, Chemical Engineering Journal, and Materials & Design. His publications primarily focus on biomaterials, injectable hydrogels, macrophage regulation, regenerative medicine, smart drug delivery, and tissue engineering applications.

Jiabing Ran has published extensively in high-impact journals indexed in SCI and Scopus databases. His publications focus on biomaterials, hydrogels, immunomodulation, tissue engineering, and controlled drug delivery technologies.[3]

  1. “Inducing in situ M2 macrophage polarization to promote the repair of bone defects via scaffold-mediated sustained delivery of luteolin.” Journal of Controlled Release, 2024. DOI: https://doi.org/10.1016/j.jconrel.2023.11.015
  2. “A multifunctional self-reinforced injectable hydrogel for enhancing repair of infected bone defects by simultaneously targeting macrophages, bacteria, and bone marrow stromal cells.” Acta Biomaterialia, 2024. DOI: https://doi.org/10.1016/j.actbio.2024.10.014
  3. “Enhancing Bone-Titanium Integration through Hydrogel Coating Mediated Sequential M1/M2 Polarization.” Chemical Engineering Journal, 2024. DOI: https://doi.org/10.1016/j.cej.2024.157088
  4. “Inducing In Situ M2 Macrophage Polarization for Tendinopathy Therapy through Microneedle Patch-Mediated Delivery.” Biomaterials Research, 2025. DOI: https://doi.org/10.1186/s40824-025-0264-0
  5. “Rational Design of a Supramolecular Hydrogel with Customizable pH-Responsiveness.” Soft Matter, 2022. DOI: https://pubs.rsc.org/en/content/articlelanding/2022/sm/d1sm01589c/unauth

Research Impact

Jiabing Ran’s research demonstrates measurable scientific impact through citation performance, translational biomaterials development, and collaborative medical applications. His h-index and citation metrics reflect continued scholarly visibility within materials science and biomedical engineering communities.[1]

His collaborations with hospitals and clinical institutes have facilitated translational research pathways for hydrogel technologies and regenerative therapeutic systems. His patents and industrial projects further indicate practical applications of his research in medical devices and biomaterial manufacturing.[5]

Award Suitability

Jiabing Ran is well recognized for his contributions to biomaterials innovation, hydrogel systems, and regenerative medicine. His interdisciplinary research integrates materials chemistry with biomedical applications, addressing important challenges in tissue repair and therapeutic delivery.[2]

The breadth of his scientific publications, funded projects, patents, and collaborative activities reflects sustained academic productivity and research leadership in emerging biomedical technologies. His work contributes to the advancement of intelligent biomaterials and therapeutic engineering strategies within modern materials science.[4]

Conclusion

Jiabing Ran has established a notable academic profile in biomedical materials science through sustained research on hydrogel technologies, smart drug delivery systems, and regenerative medicine applications. His interdisciplinary contributions to biomaterials engineering, translational therapeutic systems, and tissue regeneration continue to support innovation in modern biomedical research and clinical material science.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Jiabing Ran, Author ID 56012790200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56012790200
  2. China Three Gorges University. (2026). Academic and professional profile of Jiabing Ran and funded biomedical hydrogel research projects. https://orcid.org/0000-0002-8474-7368
  3. Ran, J. et al. (2024). Recent progress in Fenton/Fenton-like reactions for the removal of antibiotics in aqueous environments. Ecotoxicology and Environmental Safety. https://doi.org/10.1016/j.ecoenv.2022.113464
  4. Ran, J. et al. (2024). Enhancing Bone-Titanium integration through hydrogel coating mediated sequential M1/M2 polarization of interfacial macrophages. Chemical Engineering Journal. https://doi.org/10.1016/j.cej.2024.157088
  5. Ran, J. et al. (2025). Inducing In Situ M2 Macrophage Polarization for Tendinopathy Therapy through Microneedle Patch-Mediated Instant/Sustained Delivery of Rosmarinic Acid. Biomaterials Research. https://doi.org/10.1186/s40824-025-0264-0

Jaison Jeevanandam | Materials Science | Best Researcher Award

Dr.Jaison Jeevanandam | Materials Science | Best Researcher Award 

Researcher at National Institute of Mental Health | Czech Republic

Dr. Jaison Jeevanandam is a distinguished researcher and scientist recognized internationally for his contributions to materials science and nanomedicine. His academic journey reflects a multidisciplinary foundation, having pursued studies in nanoscience, nanotechnology, and chemical engineering, complemented by management education that enhances his leadership and project coordination skills. Over the course of his career, he has held key research and academic positions in Europe and Asia, contributing significantly to nanotechnology-based therapeutic innovations, sustainable materials, and biomedical formulations. His expertise spans nanoparticle synthesis, dendrimer-based drug delivery systems, and machine learning applications in nanomedicine, particularly targeting neurodegenerative and metabolic disorders. With a prolific record of scholarly achievements, he has published 153 scientific documents, accumulating 7,091 citations across 6,357 referencing documents and achieving an h-index of 32 demonstrating his global influence and research excellence. His research focuses on the intersection of materials science, biotechnology, and artificial intelligence to develop sustainable, effective, and safe solutions for healthcare and environmental challenges. Dr. Jaison Jeevanandam has served as an editor, reviewer, and scientific committee member for leading journals and international conferences, actively shaping the future direction of materials science and biomedical research. His work on green nanotechnology and smart nanomaterials contributes to advancing environmentally friendly manufacturing and therapeutic approaches. As an educator and mentor, he has guided numerous students and researchers, fostering scientific curiosity and innovation across disciplines. His recognition among the world’s top scientists underscores his commitment to excellence, collaboration, and impactful research. Through a blend of technical mastery, interdisciplinary thinking, and visionary leadership, Dr. Jaison Jeevanandam continues to advance the frontiers of nanoscience and materials engineering, developing technologies that bridge the gap between fundamental research and real-world applications. His ongoing research aims to revolutionize nanomedicine by integrating data-driven design and sustainable material development, reinforcing his role as a leading voice in global scientific innovation.

Featured Publications:

  • Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018). Review on nanoparticles and nanostructured materials: History, sources, toxicity and regulations. Beilstein Journal of Nanotechnology, 9(1), 1050-1074.

  • Ram, T. B., Krishnan, S., Jeevanandam, J., Danquah, M. K., & Thomas, S. (2024). Emerging biohybrids of aptamer-based nano-biosensing technologies for effective early cancer detection. Molecular Diagnosis & Therapy, 28(4), 425-453.

  • Jeevanandam, J. Sabbih, G., Tan, K. X., & Danquah, M. K. (2021). Oncological ligand-target binding systems and developmental approaches for cancer theranostics. Molecular Biotechnology, 63, 167-183.

  • Jeevanandam, J. Smart nanomedicines for neurodegenerative diseases: Empowering new therapies with molecular imaging and artificial intelligence.

  • Jeevanandam, J. Eco-restoration and nano-bioremediation of polluted soil using nanomaterial-synthesized biosurfactants.

  • Jeevanandam, J. Stabilization of metal-doped magnesium oxide nanoparticles with PAMAM dendrimers to improve alpha-amylase enzyme inhibition. Materials Today Bio.

  • Jeevanandam, J. Gelatin-based ballistic gel formulated with phytosynthesized nanocellulose from Arundo donax for alpha-amylase enzyme inhibition activity. Carbohydrate Polymer Technologies and Applications.